Skip to main content
. 2025 Aug 6;16:1539924. doi: 10.3389/fimmu.2025.1539924

Figure 4.

Kaplan-Meier survival curve showing overall survival (OS) over time in months for two groups: Non-POD12 with 34 cases, represented by a blue line, and POD12 with 29 cases, represented by a green line. The plot indicates a higher survival rate for the Non-POD12 group.

Effect of POD12 on OS in patients with DLBCL.